Sign In
23 Dec 2020 09:00
REDX PHARMA PLC
("Redx" or "the Company")
Share Purchases by Directors
Alderley Park, 23 December 2020 - Redx Pharma (AIM:REDX), the drug discovery and development Group focused on cancer and fibrosis, announces that it has been notified that Lisa Anson, Chief Executive Officer, has on Tuesday 22 December acquired 39,998 Redx ordinary shares at the following prices:
Number of Ordinary shares purchased | Price per share (pence) |
39,998 | 50p |
Following this, Mrs Anson will hold 129,284 ordinary shares in the Company, representing 0.05 per cent. of the issued share capital.
-Ends-
For further information, please contact:
Redx Pharma Plc | T: +44 1625 469 918 |
Lisa Anson, Chief Executive Officer James Mead, Chief Financial Officer |
|
|
|
SPARK Advisory Partners (Nominated Advisor) | T: +44 203 368 3550 |
Matt Davis/ Adam Dawes |
|
|
|
WG Partners LLP (Broker) | T: +44 20 3705 9330 |
Claes Spång/ Chris Lee/ David Wilson |
|
|
|
| |
FTI Consulting | T: +44 20 3727 1000 |
Simon Conway/Ciara Martin |
|
About Redx Pharma Plc
Redx is a UK biotechnology Group whose shares are traded on AIM (AIM:REDX). Redx is focused on creating and developing first, or potentially best in class drugs, in specific areas of cancer and fibrosis that address significant unmet medical need. Redx has an in-house discovery team with proven world-class chemistry capabilities.
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||
1 | Details of the person discharging managerial responsibilities/person closely associated | |
a. | Name | Lisa Anson |
2 | Reason for notification |
|
a. | Position/Status | Chief Executive |
b. | Initial notification/ Amendment | Initial Notification |
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |
a. | Name | Redx Pharma Plc |
b. | LEI | 213800HMS4EBXO589Y37 |
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares of 1p each ISIN: GB00BSNB6S51 |
b. | Nature of the transaction | Purchase |
c. | Price(s) and volume(s) | 39,998 at 50 pence per share
|
d. | Aggregated information - Aggregated Volume - Price | 39,998 at 50 pence per share |
e. | Date of the transaction | 22/12/20 |
f. | Place of the transaction | Outside of trading venue |
Follow the stocks
